{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:02:59Z","timestamp":1792825379835,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01603-x","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:35:05Z","timestamp":1790246105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Value of the C-Reactive Protein\u2013Albumin\u2013Lymphocyte Index in Hepatobiliary and Pancreatic Cancers: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Mohammadsadra","family":"Shamohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Arianezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danial","family":"Yarahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana Ehsan","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Teymoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubayer","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Nikkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Tizmaghz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Yahya","family":"Zarghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"3","key":"1603_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1603_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00428-024-03744-5","volume":"484","author":"T Longerich","year":"2024","unstructured":"Longerich T, Stenzinger A, Schirmacher P. Molecular diagnostics of hepatobiliary and pancreatic neoplasias. Virchows Arch. 2024;484(2):263\u201372.","journal-title":"Virchows Arch"},{"issue":"1","key":"1603_CR3","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1603_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.21873\/anticanres.17519","volume":"45","author":"T Aoyama","year":"2025","unstructured":"Aoyama T, Hara K, Saito A, Cho H. Adjuvant treatment for resectable pancreatic cancer. Anticancer Res. 2025;45(4):1329\u201341.","journal-title":"Anticancer Res"},{"issue":"7","key":"1603_CR5","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.3390\/curroncol30070482","volume":"30","author":"JJ Biagi","year":"2023","unstructured":"Biagi JJ, Cosby R, Bahl M, Elfiki T, Goodwin R, Hallet J, et al. Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline. Curr Oncol. 2023;30(7):6575\u201386.","journal-title":"Curr Oncol"},{"issue":"2","key":"1603_CR6","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1603_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/bjc.2014.90","volume":"110","author":"CS Roxburgh","year":"2014","unstructured":"Roxburgh CS, McMillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer. 2014;110(6):1409\u201312.","journal-title":"Br J Cancer"},{"issue":"5","key":"1603_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187\u201396.","journal-title":"Clin Nutr"},{"issue":"1","key":"1603_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1186\/s12885-020-07482-0","volume":"20","author":"S Sun","year":"2020","unstructured":"Sun S, He C, Wang J, Huang X, Wu J, Li S. The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy. BMC Cancer. 2020;20(1):981.","journal-title":"BMC Cancer"},{"issue":"18","key":"1603_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.21037\/atm-20-4053","volume":"8","author":"D Han","year":"2020","unstructured":"Han D, Zhang J, Zhao J, Lei T, Chen X, Zhang T, et al. Platelet-to-lymphocyte ratio is an independent predictor of chemoradiotherapy-related esophageal fistula in esophageal cancer patients. Ann Transl Med. 2020;8(18):1163.","journal-title":"Ann Transl Med"},{"issue":"23","key":"1603_CR11","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212\u201322.","journal-title":"Clin Cancer Res"},{"key":"1603_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13195018","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller L, Hahn F, M\u00e4hringer-Kunz A, Stoehr F, Gairing SJ, Michel M, et al. Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: evaluation of the CALLY index. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13195018.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"1603_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ncpgasthep0359","volume":"2","author":"S Vermeire","year":"2005","unstructured":"Vermeire S, Van Assche G, Rutgeerts P. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2(12):580\u20136.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"1603_CR14","doi-asserted-by":"crossref","unstructured":"Almasaudi AS, Dolan RD, Edwards CA, McMillan DC. Hypoalbuminemia Reflects Nutritional Risk, Body Composition and Systemic Inflammation and Is Independently Associated with Survival in Patients with Colorectal Cancer. Cancers (Basel). 2020;12(7).","DOI":"10.3390\/cancers12071986"},{"issue":"3","key":"1603_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41416-022-02119-4","volume":"128","author":"K Brummel","year":"2023","unstructured":"Brummel K, Eerkens AL, de Bruyn M, Nijman HW. Tumour-infiltrating lymphocytes: from prognosis to treatment selection. Br J Cancer. 2023;128(3):451\u20138.","journal-title":"Br J Cancer"},{"issue":"3","key":"1603_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ags3.12637","volume":"7","author":"M Tsunematsu","year":"2023","unstructured":"Tsunematsu M, Haruki K, Taniai T, Tanji Y, Shirai Y, Furukawa K, et al. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy. Ann Gastroenterol Surg. 2023;7(3):503\u201311.","journal-title":"Ann Gastroenterol Surg"},{"key":"1603_CR17","doi-asserted-by":"crossref","unstructured":"Shamohammadi M, Yarahmadi D, Yiasemidou M, Teymoori MH, Rouzbahani AK, Bahrdoust M et al. Prognostic Value of Pretreatment C-Reactive-Protein-Albumin-Lymphocyte Index in Colorectal Cancer: Systematic Review and Meta-Analysis. J Gastrointest Cancer. 2026;57(1).","DOI":"10.1007\/s12029-026-01446-6"},{"issue":"10","key":"1603_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100557","volume":"4","author":"H Toyoda","year":"2022","unstructured":"Toyoda H, Johnson PJ. The ALBI score: from liver function in patients with HCC to a general measure of liver function. JHEP Rep. 2022;4(10):100557.","journal-title":"JHEP Rep"},{"issue":"12","key":"1603_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/17474124.2024.2442573","volume":"18","author":"R Pantea","year":"2024","unstructured":"Pantea R, Bednarsch J, Schmitz S, Meister P, Heise D, Ulmer F, et al. The assessment of impaired liver function and prognosis in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2024;18(12):779\u201394.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/nu17193064","volume":"17","author":"SL Yoon","year":"2025","unstructured":"Yoon SL, Grundmann O, Rogers S, Schlaeger JM, Han B, Agyare E, et al. Cachexia in Pancreatic Cancer: New Insights to Impact Quality of Life and Survival. Nutrients. 2025;17:19.","journal-title":"Nutrients"},{"issue":"6","key":"1603_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4251\/wjgo.v8.i6.498","volume":"8","author":"BR Boulay","year":"2016","unstructured":"Boulay BR, Birg A. Malignant biliary obstruction: From palliation to treatment. World J Gastrointest Oncol. 2016;8(6):498\u2013508.","journal-title":"World J Gastrointest Oncol"},{"key":"1603_CR22","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1603_CR23","doi-asserted-by":"crossref","unstructured":"Wohlin C. Guidelines for snowballing in systematic literature studies and a replication in software engineering. Proceedings of the 18th International Conference on Evaluation and Assessment in Software Engineering; London, England, United Kingdom: Association for Computing Machinery; 2014. p. Article 38.","DOI":"10.1145\/2601248.2601268"},{"key":"1603_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1603_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2236640","volume":"55","author":"KX Sun","year":"2023","unstructured":"Sun KX, Xu RQ, Rong H, Pang HY, Xiang TX. Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis. Ann Med. 2023;55(2):2236640.","journal-title":"Ann Med"},{"key":"1603_CR26","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"998588","DOI":"10.3389\/fpubh.2023.998588","volume":"11","author":"Y Xun","year":"2023","unstructured":"Xun Y, Guo Q, Ren M, Liu Y, Sun Y, Wu S, et al. Characteristics of the sources, evaluation, and grading of the certainty of evidence in systematic reviews in public health: A methodological study. Front Public Health. 2023;11:998588.","journal-title":"Front Public Health"},{"key":"1603_CR28","doi-asserted-by":"crossref","unstructured":"\u00c7\u0131takkul \u0130, Kefeli U, Shukurova K, Aytin Z, Temi YB, Baydar E et al. Real-World Evaluation of the HELPP Score and CALLY Index for Preoperative Prognostic Stratification in Resectable Pancreatic Ductal Adenocarcinoma. J Clin Med. 2025;15(1).","DOI":"10.3390\/jcm15010312"},{"key":"1603_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1713495","volume":"17","author":"R Fan","year":"2026","unstructured":"Fan R, Lv Z, Wang T, Chen W, Han W, Mei Q. A compass in the challenge: the CALLY index as a prognostic biomarker in advanced cholangiocarcinoma treated with chemoimmunotherapy: a retrospective propensity score-matched cohort study. Front Immunol. 2026;17:1713495.","journal-title":"Front Immunol"},{"issue":"1","key":"1603_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.hpb.2021.06.414","volume":"24","author":"H Iida","year":"2022","unstructured":"Iida H, Tani M, Komeda K, Nomi T, Matsushima H, Tanaka S, et al. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2022;24(1):101\u201315.","journal-title":"HPB (Oxford)"},{"issue":"1","key":"1603_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00423-024-03512-8","volume":"409","author":"S Kawahara","year":"2024","unstructured":"Kawahara S, Aoyama T, Murakawa M, Kanemoto R, Matsushita N, Hashimoto I, et al. Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer. Langenbecks Arch Surg. 2024;409(1):317.","journal-title":"Langenbecks Arch Surg"},{"key":"1603_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051107","author":"H Kosaka","year":"2022","unstructured":"Kosaka H, Ueno M, Komeda K, Hokuto D, Iida H, Hirokawa F, et al. The impact of a preoperative staging system on accurate prediction of prognosis in intrahepatic cholangiocarcinoma. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14051107.","journal-title":"Cancers (Basel)"},{"key":"1603_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1543665","volume":"12","author":"SQ Lang","year":"2025","unstructured":"Lang SQ, Kong JJ, Li GB, Liu J. Prognostic value of CRP-albumin-lymphocyte index in patients with intrahepatic cholangiocarcinoma after radical resection. Front Med (Lausanne). 2025;12:1543665.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"1603_CR34","doi-asserted-by":"publisher","first-page":"963","DOI":"10.21873\/anticanres.18002","volume":"46","author":"S Matsui","year":"2026","unstructured":"Matsui S, Kato Y, Ohgi K, Ashida R, Otsuka S, Dei H, et al. Clinical Relevance of the CALLY Index in Prognostic Stratification of Intrahepatic Cholangiocarcinoma. Anticancer Res. 2026;46(2):963\u201374.","journal-title":"Anticancer Res"},{"key":"1603_CR35","doi-asserted-by":"crossref","unstructured":"Matsumoto Y, Otsuka Y, Hosaka H, Kajiwara Y, Okada R, Ito Y et al. Preoperative low C-reactive protein-albumin-lymphocyte (CALLY) index is a poor prognostic indicator for overall survival in patients undergoing surgery for pancreatic ductal adenocarcinoma. Surg Today. 2026.","DOI":"10.1007\/s00595-026-03270-8"},{"issue":"1","key":"1603_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00423-024-03474-x","volume":"409","author":"S Yasuda","year":"2024","unstructured":"Yasuda S, Matsuo Y, Doi S, Sakata T, Nagai M, Nakamura K, et al. Preoperative predictors of very early recurrence in patients with hepatocellular carcinoma beyond the Milan criteria. Langenbecks Arch Surg. 2024;409(1):283.","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"1603_CR37","doi-asserted-by":"publisher","first-page":"20090","DOI":"10.1038\/s41598-025-03985-7","volume":"15","author":"H Zhao","year":"2025","unstructured":"Zhao H, Yin B, Li XR, Liu XY, Bu ZT, Shi HP. The CRP-albumin-lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system. Sci Rep. 2025;15(1):20090.","journal-title":"Sci Rep"},{"key":"1603_CR38","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.2147\/IJGM.S529776","volume":"18","author":"L Zhu","year":"2025","unstructured":"Zhu L, Kong Y, Xing Y, Wang M. The prognostic and early efficacy prediction value of baseline C-reactive protein-albumin-lymphocyte (CALLY) index in advanced pancreatic cancer. Int J Gen Med. 2025;18:3363\u201372.","journal-title":"Int J Gen Med"},{"issue":"1","key":"1603_CR39","doi-asserted-by":"publisher","first-page":"100119","DOI":"10.1016\/j.soi.2024.100119","volume":"2","author":"M Satoshi","year":"2025","unstructured":"Satoshi M, Yoshiyasu K, Katsuhisa O, Ryo A, Mihoko Y, Shimpei O, et al. Prognostic impact of the CALLY index in patients with resectable pancreatic cancer. Surg Oncol Insight. 2025;2(1):100119.","journal-title":"Surg Oncol Insight"},{"issue":"8","key":"1603_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/medicina62081517","volume":"62","author":"KF I\u015f\u0131ker","year":"2026","unstructured":"I\u015f\u0131ker KF, Sar\u0131ta\u015f AG, Topal U, Ayd\u0131n \u0130, G\u00fcm\u00fc\u015f S, Yavuz B, et al. Utility of the C-Reactive protein\u2013albumin\u2013lymphocyte (CALLY) index in prognostic assessment of pancreatic head adenocarcinomas undergoing pancreaticoduodenectomy. Medicina. 2026;62(8):1517.","journal-title":"Medicina"},{"issue":"5","key":"1603_CR41","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.21873\/invivo.14436","volume":"40","author":"T Sakamoto","year":"2026","unstructured":"Sakamoto T, Urakami K, Uehira K, Yoshida J, Kishino M, Morimoto M, et al. Clinical impact of the C-Reactive protein-albumin-lymphocyte index as a prognostic biomarker in patients with recurrent pancreatic cancer. In Vivo. 2026;40(5):2864\u201371.","journal-title":"In Vivo"},{"key":"1603_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/or.2026.1737805","volume":"20","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Liu W. The CALLY index in cancer research: a comprehensive review. Oncol Rev. 2026;20:1737805.","journal-title":"Oncol Rev"},{"issue":"12","key":"1603_CR43","doi-asserted-by":"publisher","first-page":"e0143080","DOI":"10.1371\/journal.pone.0143080","volume":"10","author":"S Shrotriya","year":"2015","unstructured":"Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS ONE. 2015;10(12):e0143080.","journal-title":"PLoS ONE"},{"issue":"Suppl 3","key":"1603_CR44","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1007\/s11739-012-0802-0","volume":"7","author":"A Gatta","year":"2012","unstructured":"Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7(Suppl 3):S193\u20139.","journal-title":"Intern Emerg Med"},{"issue":"2","key":"1603_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. J Parenter Enter Nutr. 2019;43(2):181\u201393.","journal-title":"J Parenter Enter Nutr"},{"issue":"1","key":"1603_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-020-1094-5","volume":"20","author":"J Zhao","year":"2020","unstructured":"Zhao J, Huang W, Wu Y, Luo Y, Wu B, Cheng J, et al. Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis. Cancer Cell Int. 2020;20(1):15.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"1603_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00595-024-02921-y","volume":"55","author":"J Li","year":"2025","unstructured":"Li J, Zhang S, Hu X, Huang T, Chen M. Correlation between the C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index and the prognosis of gastric cancer patients after gastrectomy: a systematic review and meta-analysis. Surg Today. 2025;55(4):483\u201391.","journal-title":"Surg Today"},{"issue":"9","key":"1603_CR48","first-page":"e93594","volume":"17","author":"W Ul Bassar","year":"2025","unstructured":"Ul Bassar W, Akhtar J, Mukhtar Ismail NH, Shah Z, Kaur Dhanjal M, Chaudhary S, et al. The C-reactive Protein-Albumin-Lymphocyte Index Predicts Survival Outcomes in Esophageal Cancer: A Meta-Analysis. Cureus. 2025;17(9):e93594.","journal-title":"Cureus"},{"issue":"1","key":"1603_CR49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12957-025-03779-1","volume":"23","author":"D Chen","year":"2025","unstructured":"Chen D, Ma Y, Li J, Wen L, Liu L, Su J, et al. Prognostic and clinicopathological significance of C-reactive protein\u2013albumin\u2013lymphocyte(CALLY) in patients with digestive system neoplasms: a systematic review and meta-analysis. World J Surg Oncol. 2025;23(1):114.","journal-title":"World J Surg Oncol"},{"key":"1603_CR50","doi-asserted-by":"publisher","first-page":"k4597","DOI":"10.1136\/bmj.k4597","volume":"364","author":"RD Riley","year":"2019","unstructured":"Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, et al. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ. 2019;364:k4597.","journal-title":"BMJ"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01603-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:35:09Z","timestamp":1790246109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01603-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01603-x","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a systematic review and meta-analysis of published, de-identified data and did not involve direct contact with human participants.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Human Ethics and Consent to Participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PROSPERO CRD420261370188.","order":5,"name":"Ethics","label":"Protocol Registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"224"}}